Europe Monoclonal Antibodies Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Europe Monoclonal Antibodies Market is Segmented by Method (In Vivo and In Vitro), Source (Chimeric, Human, Humanized, and Murine), Indication (Oncology, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, and Other Indications), End User (Hospitals, Research and Academic Centers, and Other End Users), and Geography (Germany, United Kingdom, France, Italy, Spain, and Rest of Europe). The report offers the value (in USD million) for the above segments.

Europe Monoclonal Antibodies Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Europe Monoclonal Antibodies Industry Overview

The Europe monoclonal antibodies market is consolidated due to a few large companies dominating the majority of the market share. The prominent players are actively participating in the launch of mAbs for various applications. Some of the key players in the market include Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Novartis AG, Merck KGaA, and Pfizer Inc., among others.

Europe Monoclonal Antibodies Market Leaders

  1. Eli Lilly and Company

  2. F. Hoffmann-La Roche Ltd

  3. Novartis AG

  4. Merck KGaA

  5. Pfizer Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Europe Monoclonal Antibodies Market Concentration

Europe Monoclonal Antibodies Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?